fbpx
Medical Innovation Exchange

Weight watcher: Innovent catching up with Lilly, Novo Nordisk thanks to phase 2 obesity data

https://www.fiercebiotech.com/biotech/weight-watcher-innovent-catching-lilly-novo-nordisk-phase-2-obesity-results

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.